CTOs on the Move


 
Headquartered near Zurich, Switzerland, Phonak, a member of the Sonova Group, was born in 1947 from a passion and dedication to take on the most difficult hearing challenges. As the industry`s leading provider, we offer the broadest portfolio of life-changing hearing solutions. From pediatric to profound hearing loss, we remain committed to creating hearing solutions that change people`s lives to thrive socially and emotionally. We believe in changing lives and creating a world where `Life is on` for everyone.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.phonak.com
  • 750 North Commons Drive
    Aurora, IL USA 60504
  • Phone: 888.777.7316

Executives

Name Title Contact Details

Similar Companies

SouthwestMedical.com

SouthwestMedical.com is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

REZSTREAM

REZSTREAM is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vanguard Advanced Pharmacy Systems Inc

Vanguard Advanced Pharmacy Systems Inc is a Bradenton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.

OraSure

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure`s portfolio of products is sold globally to clinical laboratories, hospitals, physician`s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.